Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-18
SponsorCentre Hospitalier Universitaire de Nice
About this trial
The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.
Eligibility criteria
Qualifiers
Minor patients (<18 years)
Patients of both sexes
Informed patients and parents who have signed the informed consent form
Patients affiliated to social security
Disqualifiers
Progressive cancer or kidney disease
Treatments that may modify PPi concentration (e.g. bisphosphonates)
Trial design
Treatments tested in this trial
- PPI and T50 dosing
Treatment groups
60 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov